Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Chelidonium Majus, Iodium, Lycopus Virginicus, Ginkgo Biloba, Pinus Sylvestris, Fucus Vesiculosus, Spongia Tosta, Germanium Sesquioxide, Hypophysis Suis, Thyroidinum (suis), Cysteinum, Manganese Gluconate, Alpha-ketoglutaricum Acidum, Calcarea Carbonica, Ferrum Iodatum, Fumaricum Acidum, Kali Iodatum, Natrum Oxalaceticum, Pulsatilla (vulgaris), Argentum Metallicum, Aurum Metallicum, Cuprum Metallicum, Eugenol, Formalinum, Lidocaine, Mercurius Solubilis, Molybdenum Metallicum, Niccolum Metallicum,
Brand Name
Oligo Bio Iodine
Generic Name
Chelidonium Majus, Iodium, Lycopus Virginicus, Ginkgo Biloba, Pinus Sylvestris, Fucus Vesiculosus, Spongia Tosta, Germanium Sesquioxide, Hypophysis Suis, Thyroidinum (suis), Cysteinum, Manganese Gluconate, Alpha-ketoglutaricum Acidum, Calcarea Carbonica, Ferrum Iodatum, Fumaricum Acidum, Kali Iodatum, Natrum Oxalaceticum, Pulsatilla (vulgaris), Argentum Metallicum, Aurum Metallicum, Cuprum Metallicum, Eugenol, Formalinum, Lidocaine, Mercurius Solubilis, Molybdenum Metallicum, Niccolum Metallicum,
Active Ingredient
Chelidonium Majus WholeCategory
Non-Standardized Plant Allergenic Extract [EPC]
Variants
2
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 3 [hp_X]/mL | LIQUID | ORAL | 43857-0541 |
| 3 [hp_X]/mL | LIQUID | ORAL | 43857-0603 |
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Oligo Bio Iodine, you must consult a qualified healthcare professional.
Detailed information about Oligo Bio Iodine
Chelidonium Majus Whole is a botanical extract classified primarily as a Non-Standardized Plant Allergenic Extract, used in diagnostic testing and specific therapeutic contexts involving alkaloid activity.
Dosage for Chelidonium Majus Whole varies drastically depending on the intended use and the specific formulation. There is no universal 'standard' dose because it is a non-standardized extract.
Chelidonium Majus Whole is generally not recommended for pediatric use unless specifically directed by a specialist in allergenic medicine. The risk of alkaloid-induced toxicity and the lack of safety data in children make it a high-risk substance for minors. For allergy testing in children, clinicians must use the lowest possible concentration to avoid systemic reactions.
Patients with impaired kidney function should use Chelidonium Majus Whole with extreme caution. While the primary route of alkaloid clearance is hepatic, renal excretion of metabolites plays a secondary role. A reduction in frequency or dose may be necessary to prevent accumulation.
Chelidonium Majus Whole is contraindicated in patients with active liver disease. Because the extract is known to cause idiosyncratic hepatotoxicity (liver damage), those with pre-existing hepatic impairment, hepatitis, or cirrhosis should avoid this substance entirely.
Geriatric patients often have reduced hepatic blood flow and diminished metabolic capacity. Dosing should start at the lowest end of the spectrum, with frequent monitoring of liver enzymes (ALT, AST).
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up, as this increases the risk of liver toxicity.
Signs of overdose include severe nausea, vomiting, burning sensation in the mouth and throat, bloody diarrhea (due to the caustic nature of sanguinarine), and signs of acute liver failure (yellowing of the eyes/skin). In case of suspected overdose, contact a poison control center or seek emergency medical attention immediately. Treatment is primarily supportive, focusing on gastric lavage and monitoring liver function.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance. The therapeutic window for this botanical extract is narrow.
When used topically or in concentrated oral forms, Chelidonium Majus Whole may cause:
Chelidonium Majus Whole contains potent alkaloids that can be toxic if misused. It should never be used as a primary treatment for serious medical conditions without the oversight of a qualified medical professional. The extract's status as a 'Non-Standardized' substance means that potency can vary significantly between batches, increasing the risk of accidental overdose or toxicity.
While there is no official FDA Black Box Warning, clinicians treat Chelidonium Majus with the same caution as other hepatotoxic agents. The primary concern is Idiosyncratic Hepatotoxicity, which can occur at any dose and is not always dose-dependent. This means even small amounts can trigger severe liver inflammation in susceptible individuals.
Chelidonium Majus Whole must NEVER be used in the following circumstances:
Chelidonium Majus Whole is considered unsafe during pregnancy. The isoquinoline alkaloids can cross the placental barrier. Studies in animal models have suggested that these compounds can be embryotoxic. Furthermore, the plant has traditional use as an emmenagogue (substance that stimulates menstrual flow) and abortifacient. Its use during any trimester poses a significant risk of uterine contractions and potential fetal demise. If exposure occurs, immediate obstetric consultation is required.
It is unknown if the alkaloids from Chelidonium Majus Whole are excreted in human breast milk. However, many alkaloids are known to pass into milk and could potentially cause sedation, digestive upset, or liver strain in a nursing infant. Because of the potential for serious toxicity, breastfeeding is not recommended while using this substance.
Safety and effectiveness in pediatric populations have not been established. The use of Chelidonium Majus Whole in children is generally avoided due to the risk of idiosyncratic reactions and the vulnerability of the pediatric liver to alkaloid-induced damage. In rare cases where it is used for allergy testing, it must be performed by a pediatric allergist in a controlled clinical setting.
Chelidonium Majus Whole acts through a complex interplay of various alkaloids. The primary component, chelidonine, acts as a mild sedative and antispasmodic, specifically targeting the smooth muscles of the biliary tract. It is thought to inhibit phosphodiesterase enzymes, leading to increased levels of cAMP and subsequent muscle relaxation.
Another major mechanism is Cholinesterase Inhibition. By inhibiting the enzyme acetylcholinesterase, the extract increases the availability of acetylcholine. This contributes to its 'pro-kinetic' effects in the upper GI tract but can also lead to cholinergic side effects. The Ammonium Ion Binding Activity refers to the ability of quaternary alkaloids (like coptisine) to interact with anionic sites on proteins and cell membranes, which may explain its antimicrobial and cytotoxic properties in vitro.
The onset of action for gastrointestinal effects is typically 30 to 60 minutes after oral administration. The duration of effect is approximately 4 to 6 hours. Tolerance to the antispasmodic effects has not been widely reported, but the risk of toxicity increases significantly with repeated dosing over time.
Common questions about Oligo Bio Iodine
Chelidonium Majus Whole is primarily used as a diagnostic tool in allergy testing to identify hypersensitivity to the Greater Celandine plant. In traditional and botanical medicine, it is sometimes used to treat biliary disorders, such as gallbladder pain or indigestion, due to its antispasmodic properties. It is also used topically in some cultures to treat skin conditions like warts. However, its use is strictly limited in modern medicine due to the high risk of liver toxicity. Always consult a healthcare provider before using it for any therapeutic purpose.
The most common side effects include gastrointestinal issues such as nausea, stomach cramps, and diarrhea. When applied to the skin for testing or treatment, it frequently causes localized redness, itching, and a burning sensation. Some patients also report dizziness or a dry mouth after taking oral preparations. Because it is a potent botanical, even common side effects should be monitored closely. If these symptoms persist or worsen, medical advice should be sought immediately.
No, you should strictly avoid alcohol while taking Chelidonium Majus Whole. Both alcohol and the alkaloids in this extract are processed by the liver, and combining them significantly increases the risk of severe liver damage or acute hepatitis. Alcohol can also worsen the dizziness and stomach upset associated with the extract. To protect your liver health, it is essential to remain abstinent from alcohol during the entire course of treatment. Discuss any concerns about alcohol use with your doctor.
Chelidonium Majus Whole is considered unsafe during pregnancy and should be avoided. It contains alkaloids like sanguinarine that can stimulate uterine contractions, potentially leading to miscarriage or preterm labor. There is also a lack of safety data regarding its effects on fetal development, with some animal studies suggesting potential harm. If you are pregnant or planning to become pregnant, inform your healthcare provider immediately. They will recommend safer alternatives for your condition.
For diagnostic allergy testing, a reaction (like a hive or redness) typically appears within 15 to 20 minutes of application. For oral use in treating digestive symptoms, patients may notice an effect within 30 to 60 minutes as the antispasmodic alkaloids begin to work. However, therapeutic effects for chronic conditions are not well-established, and the drug should not be used long-term. If you do not see an improvement in symptoms within a few days, contact your doctor. Never increase the dose to speed up the results.
Yes, you can generally stop taking Chelidonium Majus Whole suddenly, as it does not cause physical dependence or a typical withdrawal syndrome. In fact, if you experience any signs of liver trouble, such as yellowing of the skin or dark urine, you must stop taking it immediately. However, you should always inform your healthcare provider before stopping a prescribed regimen. They can help determine if your symptoms require a different treatment approach. Stopping the medication will not cause rebound symptoms in most cases.
If you miss a dose, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, skip the missed dose and continue with your regular dosing schedule. Do not take two doses at once to make up for the one you missed, as this significantly increases the risk of liver toxicity. Keeping a consistent schedule helps maintain the therapeutic level of the extract while minimizing risks. If you miss multiple doses, consult your healthcare provider for guidance.
There is no clinical evidence to suggest that Chelidonium Majus Whole causes weight gain. Most of its side effects are related to the gastrointestinal and hepatic systems, which are more likely to cause a temporary loss of appetite or weight loss if toxicity occurs. If you notice rapid or unexplained weight changes while taking this substance, it is likely due to another underlying condition or medication. Discuss any significant weight changes with your doctor to identify the cause. Always track your symptoms when starting a new extract.
Chelidonium Majus Whole has many potential drug interactions, especially with medications that affect the liver or heart rhythm. It should never be taken with other hepatotoxic drugs like acetaminophen or methotrexate. It can also interact with blood thinners, diabetes medications, and antiarrhythmics. Because of these risks, you must provide your doctor with a full list of all medications, herbs, and supplements you are currently taking. They will determine if the combination is safe for you.
Chelidonium Majus Whole is a botanical extract, not a synthetic drug, so the concept of 'generic' vs. 'brand name' is slightly different. It is available from various manufacturers as a non-standardized extract or homeopathic preparation. While these products may contain the same plant species, their potency and purity can vary significantly between brands. It is important to use a high-quality product from a reputable source recommended by your healthcare provider. Always check the label for the specific concentration of the extract.
Other drugs with the same active ingredient (Chelidonium Majus Whole)
> Warning: Stop taking Chelidonium Majus Whole and call your doctor immediately if you experience any of these.
Prolonged use of Chelidonium Majus Whole (beyond 4 weeks) is strongly discouraged. Chronic exposure to its isoquinoline alkaloids can lead to cumulative liver damage, even if initial doses are well-tolerated. There is also a theoretical risk of 'alkaloidism,' characterized by chronic digestive upset and neurological tremors, though this is rarely documented in modern clinical settings with controlled doses.
No FDA black box warnings currently exist for Chelidonium Majus Whole as an allergenic extract. However, several European regulatory agencies (such as the BfArM in Germany) have issued stern warnings regarding its hepatotoxic potential. If this were a standard pharmaceutical, a warning regarding Drug-Induced Liver Injury (DILI) would likely be mandated. Patients must be aware that 'natural' does not mean 'safe,' especially concerning the liver.
Report any unusual symptoms to your healthcare provider immediately. Monitoring of liver enzymes is recommended for any patient using this substance for more than two weeks.
If a healthcare provider prescribes Chelidonium Majus Whole for an extended period (not recommended), the following monitoring is essential:
Chelidonium Majus Whole may cause dizziness or somnolence in some patients. Do not drive or operate heavy machinery until you know how this medication affects you. The risk is increased if the extract is taken alongside other sedating substances.
Alcohol should be strictly avoided. Alcohol increases the metabolic strain on the liver and can potentiate the hepatotoxic effects of the alkaloids in Chelidonium Majus. Furthermore, alcohol can worsen the gastrointestinal side effects of the extract.
While there is no documented withdrawal syndrome associated with Chelidonium Majus Whole, it should be discontinued immediately if any signs of liver dysfunction or severe allergic reaction occur. Tapering is generally not required for botanical extracts of this nature unless they have been used at very high doses for a prolonged period.
> Important: Discuss all your medical conditions with your healthcare provider before starting Chelidonium Majus Whole. Ensure they are aware of any history of hepatitis or gallbladder disease.
Chelidonium Majus Whole may interfere with:
For each major interaction, the mechanism usually involves CYP450 enzyme competition or additive pharmacodynamic toxicity. Management typically involves avoiding the combination or performing rigorous baseline and follow-up lab work.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete medication reconciliation is the only way to prevent dangerous interactions.
Conditions requiring careful risk-benefit analysis include:
Patients allergic to Papaver somniferum (Opium Poppy), Eschscholzia californica (California Poppy), or Sanguinaria canadensis (Bloodroot) may experience cross-allergic reactions to Chelidonium Majus Whole. Diagnostic testing should be approached with extreme caution in these individuals.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Chelidonium Majus Whole. Do not self-initiate treatment if you have any history of organ dysfunction.
Elderly patients are at a higher risk for adverse effects. Age-related declines in hepatic and renal function can lead to higher systemic concentrations of alkaloids. There is also an increased risk of falls if the substance causes dizziness. Polypharmacy is common in this age group, significantly increasing the likelihood of drug-drug interactions. Clinicians should use the lowest possible dose and monitor LFTs more frequently.
While the liver is the primary organ of concern, the kidneys clear the water-soluble metabolites of the alkaloids. In patients with a GFR (Glomerular Filtration Rate) below 30 mL/min, the clearance of these metabolites is significantly delayed. No specific dosing guidelines exist, but extreme caution and dose reduction are advised.
This is a critical contraindication. Patients with Child-Pugh Class A, B, or C hepatic impairment should not use Chelidonium Majus Whole. The risk of drug-induced liver injury (DILI) is significantly amplified in these patients, and the extract may accelerate the progression of liver failure.
> Important: Special populations require individualized medical assessment. Always inform your specialist of your pregnancy status or any chronic organ conditions.
| Parameter | Value |
|---|---|
| Bioavailability | <5% (for primary alkaloids like Berberine) |
| Protein Binding | 80-90% (estimated for chelidonine) |
| Half-life | 3-6 hours (alkaloid dependent) |
| Tmax | 1.5 - 2 hours |
| Metabolism | Hepatic (CYP3A4, CYP2D6) |
| Excretion | Fecal (60-70%), Renal (20-30%) |
Chelidonium Majus Whole is classified as a Non-Standardized Plant Allergenic Extract [EPC]. It is related to other Papaveraceae extracts but is unique due to its specific ratio of chelidonine to sanguinarine, which distinguishes its pharmacological profile from the opium poppy.